Retrospective study of cetuximab concurrent with postoperative radiation in poor risk patients with resected squamous cell carcinomas of the head and neck.

Trial Profile

Retrospective study of cetuximab concurrent with postoperative radiation in poor risk patients with resected squamous cell carcinomas of the head and neck.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2015

At a glance

  • Drugs Cetuximab (Primary)
  • Indications Head and neck cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jul 2015 New trial record
    • 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top